ROCKVILLE, Md. — U.S.Pharmacopeia (USP), an independent scientific organization, announces the USP Medicine Supply Vulnerability Insights Series sourced from USP’s global Medicine Supply Map. The first of its kind, the USP Medicine Supply Map leverages insights derived from the use of USP quality standards in more than 22 thousand locations around the world, spanning 92 percent
ROCKVILLE, Md. – U.S. Pharmacopeia (USP), a global independent scientific organization, is seeking scientific input on new draft guidelines, “Analytical Procedures for mRNA Vaccine Quality.” USP and a group of leading mRNA experts have identified the need for analytical procedures and best practices to support quality assessments for mRNA vaccines and therapies in development pipelines
ROCKVILLE, Md. — Beginning Monday, June 15, the U.S. Pharmacopeia (USP) is donating samples of four monoclonal antibody (mAb) Reference Standards, including three new standards just released, to researchers developing mAb-based treatments for COVID-19. The offer is part of USP’s new Trust Accelerated program to support scientists, developers, and manufacturers working worldwide to speed the development of safe
ROCKVILLE, Md. — To accelerate the development of safe and effective COVID-19 vaccines, medicines and other treatments, the U.S. Pharmacopeia (USP) has launched a new program to support scientists, developers and manufacturers worldwide. In response to overwhelming demand, with 2,000 downloads of select COVID-related USP standards made available in March, Trust Accelerated offers expanded access to free
ROCKVILLE, Md. – The U.S. Pharmacopeia (USP) is offering an online toolkit with guidelines from major public health organizations on compounding alcohol-based hand sanitizers and the preparation of hand sanitizers by manufacturers, pharmacies and other facilities. The toolkit was developed to help organizations meet the demand for these products, as shortages of commercially manufactured sanitizers have occurred. The toolkit
